Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant VEGF (Bevacizumab Biosimilar) antibody

This Humanized Monoclonal antibody specifically detects VEGF (Bevacizumab Biosimilar) in ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7093077

Quick Overview for Recombinant VEGF (Bevacizumab Biosimilar) antibody (ABIN7093077)

Target

VEGF (Bevacizumab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 2
  • 1
  • 1
  • 1
  • 1
Humanized

Clonality

  • 3
  • 3
Monoclonal

Conjugate

  • 6
This VEGF (Bevacizumab Biosimilar) antibody is un-conjugated

Application

  • 4
  • 3
  • 3
  • 3
  • 3
  • 1
ELISA

Grade

Research Grade
  • Purpose

    Anti-VEGFA (bevacizumab biosimiar) mAb

    Characteristics

    MVCD1,VEGF,VPF

    Purification

    Purified from cell culture supernatant by affinity chromatography

    Isotype

    IgG1
  • Application Notes

    ELISA 1:5000-10000

    Comment

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Reconstitute with deionized water

    Buffer

    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

    Expiry Date

    12 months
  • Target

    VEGF (Bevacizumab Biosimilar)

    Alternative Name

    VEGFA (Bevacizumab Biosimiar)

    Target Type

    Biosimilar

    Background

    Synonyms: rhuMAb-VEGF

    Gene ID

    7422

    UniProt

    P15692
You are here:
Chat with us!